2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
243
Neoplasms
17
Neoplasm Metastasis
15
Carcinoma, Intraductal, Noninfiltrating
11
Breast Diseases
8
Advanced Breast Cancer
8
Breast Neoplasms, Male
7
Breast Carcinoma In Situ
7
Triple Negative Breast Neoplasms
5
Ovarian Neoplasms
5
Endometrial Neoplasms
5
Arthralgia
5
Neoplasms by Site
3
Breast Cancer Metastatic
3
Uterine Cervical Neoplasms
2
Recurrence
2
Patient Compliance
2
Osteoporosis
2
Obesity
2
Multiple Endocrine Neoplasia Type 1
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasm Female
2
Vitamin D Deficiency
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Skin Diseases
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Seizures
1
Sarcoma
1
Interventions
Cisplatin
56
Carboplatin
51
pembrolizumab
43
Paclitaxel
42
Gemcitabine
28
Pemetrexed
24
Radiotherapy
21
Magnetic Resonance Spectroscopy
20
Radiotherapy, Intensity-Modulated
18
Cetuximab
18
Docetaxel
17
Specimen Handling
16
Nivolumab
16
Fluorouracil
16
Cyclophosphamide
14
durvalumab
13
Bevacizumab
13
Sorafenib
12
Radiation
11
130-nm albumin-bound paclitaxel
11
Sunitinib
10
Platinum
10
1,2-diaminocyclohexaneplatinum II citrate
10
osimertinib
9
Oxaliplatin
8
Irinotecan
8
Ipilimumab
8
Everolimus
8
Drug Therapy
8
Capecitabine
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma
×
Anastrozole
×
Clear all
NCT02730923
2024-02-13
VICTORIA
Centre Leon Berard
Phase 1/2
Unknown
72 enrolled